BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1969915)

  • 1. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of catecholamine biosynthesis by carbidopa and metyrosine in neuroblastoma.
    Anton AH; Crumrine RS; Stern RC; Izant RJ
    Pediatr Pharmacol (New York); 1983; 3(2):107-17. PubMed ID: 6425794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monensin inhibits catecholamine synthesis in pheochromocytoma cells.
    Vaccaro KK; Liang BT; Sheard BE; Perlman RL
    J Pharmacol Exp Ther; 1982 Jun; 221(3):536-40. PubMed ID: 6123583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alpha-methyl-paratyrosine in the treatment of malignant pheochromocytoma].
    Decoulx M; Wemeau JL; Racadot-Leroy N; Grimbert I; Proye C; Plane C
    Rev Med Interne; 1987; 8(4):383-8. PubMed ID: 3423477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
    Tcherdakoff P; Ménard J; Bedrossian J; Vaysse J; Alexandre JM; Milliez P
    Sem Hop; 1972 May; 48(25):1779-87. PubMed ID: 4405188
    [No Abstract]   [Full Text] [Related]  

  • 6. [Catecholamine-producing tumors].
    Chávez Lara B
    Arch Inst Cardiol Mex; 1991; 61(6):553-9. PubMed ID: 1793308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
    Okada S; Ohshima K; Onai T; Umahara M; Kobayashi S; Ishihara H
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1221-5. PubMed ID: 1975832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
    Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M
    Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytoma resistant to alpha-adrenergic blockade.
    Hauptman JB; Modlinger RS; Ertel NH
    Arch Intern Med; 1983 Dec; 143(12):2321-3. PubMed ID: 6139989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metyrosine and pheochromocytoma.
    Steinsapir J; Carr AA; Prisant LM; Bransome ED
    Arch Intern Med; 1997 Apr; 157(8):901-6. PubMed ID: 9129550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
    Wocial B; Januszewicz W; Siedlecki I; Feltynowski T; Debiński W
    Endokrinologie; 1982 Feb; 79(1):131-9. PubMed ID: 7084126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of pheochromocytoma with the use of metyrosine.
    Perry RR; Keiser HR; Norton JA; Wall RT; Robertson CN; Travis W; Pass HI; Walther MM; Linehan WM
    Ann Surg; 1990 Nov; 212(5):621-8. PubMed ID: 1978640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma catecholamine responses to tyrosine hydroxylase inhibition and cold exposure.
    Avakian EV; Horvath SM
    Life Sci; 1980 May; 26(20):1691-6. PubMed ID: 6104766
    [No Abstract]   [Full Text] [Related]  

  • 14. [An autopsy case of extra-adrenal malignant pheochromocytoma].
    Sunaga Y; Taniguchi N; Hayashi K; Koito M; Inada M; Oyaizu N; Shikata N
    Gan No Rinsho; 1990 Sep; 36(11):2092-9. PubMed ID: 1977940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation.
    Kvetnansky R; Armando I; Weise VK; Holmes C; Fukuhara K; Deka-Starosta A; Kopin IJ; Goldstein DS
    J Pharmacol Exp Ther; 1992 Jun; 261(3):899-909. PubMed ID: 1602395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis and storage of catecholamines in pheochromocytoma and neuroblastoma cells.
    Itoh T; Omori K
    J Lab Clin Med; 1973 Jun; 81(6):889-96. PubMed ID: 4145540
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenergic blockade in pheochromocytoma.
    Modlinger RS; Ertel NH; Hauptman JB
    Arch Intern Med; 1983 Dec; 143(12):2245-6. PubMed ID: 6139986
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopa in plasma increases during acute exercise and after exercise training.
    Devalon ML; Miller TD; Squires RW; Rogers PJ; Bove AA; Tyce GM
    J Lab Clin Med; 1989 Sep; 114(3):321-7. PubMed ID: 2504856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and alpha-methyl-p-tyrosine.
    Nakagami Y; Nomura K; Kusakabe K; Miko N; Tsushima T; Demura H
    Jpn J Med; 1990; 29(3):329-33. PubMed ID: 1980321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine depletion produces irrepressible saccadic eye movements in normal humans.
    Tychsen L; Sitaram N
    Ann Neurol; 1989 May; 25(5):444-9. PubMed ID: 2570547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.